Seeing the world through the eyes of our patients
is a unique source of inspiration which drives us to
continuously strengthen our product offerings, taking
advantage of the latest medical and technological
advances to ultimately meet patient needs. Over the
years, we have continuously worked on enhancing the
product profile of Rebif®, our leading product for patients
with relapsing multiple sclerosis, with new formulations,
new delivery devices and new clinical data showing how
best the product should be used. Recent achievements
include the European approval to expand the use of Rebif®
in patients with early signs of multiple sclerosis. We
also extended our range of innovative delivery devices
for the self-administration of Rebif® with the approval
in select markets of Rebidose™, a single-use pre-filled pen.
The needs of our patients are the focus of our innovation culture. For them,
we develop pioneering therapies and solutions.
Providing independence 
Our Rebidose™ pen gives patients more independence, for example when traveling or on vacation.
back
